Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.

被引：0
|
作者：
Lee, JH [1 ]
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, YS [1 ]
Seol, M [1 ]
Ryu, SG [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：611S / 611S
页数：1
相关论文
共 50 条
  • [21] Induction and consolidation therapy with intermediate-dose cytarabine, mitoxantrone and etoposide in patients >=60 years with acute myeloid leukemia (AML).
    Shepherd, JD
    Barnett, MJ
    Brockington, DA
    Fung, HC
    Klingemann, HG
    Nantel, SH
    Reece, DE
    Sutherland, HJ
    Thierman, JG
    Toze, CL
    Phillips, GL
    BLOOD, 1995, 86 (10) : 2075 - 2075
  • [22] Efficacy and safety of mitoxantrone, etoposide, and cytarabine for treatment of relapsed or refractory acute myeloid leukemia
    Zhong, Sharon
    Kurish, Heena
    Walchack, Robert
    Li, Hong
    Edwards, Jessi
    Singh, Abhay
    Advani, Anjali
    LEUKEMIA RESEARCH, 2024, 139
  • [23] Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
    Trifilio, Steven M.
    Rademaker, Alfred W.
    Newman, Diane
    Coyle, Katherine
    Carlson-Leuer, Katrin
    Mehta, Jayesh
    Altman, Jessica
    Frankfurt, Olga
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 394 - 396
  • [24] MITOXANTRONE AND CONSTANT INFUSION ETOPOSIDE FOR RELAPSED AND REFRACTORY ACUTE MYELOCYTIC-LEUKEMIA
    PACIUCCI, PA
    DAVIS, RB
    HOLLAND, JF
    MARTELO, O
    SCHIFFER, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 516 - 519
  • [25] Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation
    Lee, JH
    Lee, KH
    Kim, S
    Seol, M
    Kim, SH
    Kim, WK
    Lee, JS
    LEUKEMIA RESEARCH, 2001, 25 (04) : 305 - 312
  • [26] IDARUBICIN IN COMBINATION WITH INTERMEDIATE-DOSE CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE LEUKEMIAS
    CARELLA, AM
    PUNGOLINO, E
    PIATTI, G
    GAOZZA, E
    NATI, S
    SPRIANO, M
    GIORDANO, D
    DAMICO, T
    DAMASIO, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 (04) : 309 - 313
  • [27] Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.
    Bhatnagar, Bhavana
    Walker, Alison R.
    Mims, Alice S.
    Vasu, Sumithira
    Klisovic, Rebecca B.
    Behbehani, Gregory
    Blachly, James Stewart
    Larkin, Karilyn T. M.
    Long, Meixiao
    Zhao, Qiuhong
    Ranganathan, Parvathi
    Byrd, John C.
    Blum, William G.
    Garzon, Ramiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia
    Ozkaynak, MF
    Avramis, VI
    Carcich, S
    Ortega, JA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (06): : 475 - 482
  • [29] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA WITH IDARUBICIN AND INTERMEDIATE-DOSE CYTARABINE
    HAROUSSEAU, JL
    REIFFERS, J
    HURTELOUP, P
    MILPIED, N
    GUY, H
    RIGALHUGUET, F
    FACON, T
    DUFOUR, P
    IFRAH, N
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 45 - 49
  • [30] SEQUENTIAL INTERMEDIATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE FOR PATIENTS WITH RELAPSED AND REFRACTORY ACUTE MYELOCYTIC-LEUKEMIA
    PACIUCCI, PA
    CUTTNER, J
    HOLLAND, JF
    AMERICAN JOURNAL OF HEMATOLOGY, 1990, 35 (01) : 22 - 25
12345